$ONVO
ORGANOVO HOLDINGS, INC.

2015 Q1 Form 10-Q Financial Statement

#000156459015000541 Filed on February 06, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q4 2014 Q1
Revenue $267.0K $155.0K $120.0K
YoY Change 122.5% 14.81% -44.19%
Cost Of Revenue $0.00
YoY Change
Gross Profit $120.0K
YoY Change -44.19%
Gross Profit Margin 100.0%
Selling, General & Admin $4.600M $3.878M $4.250M
YoY Change 8.24% 63.01% 52.22%
% of Gross Profit 3541.67%
Research & Development $3.640M $3.240M $2.550M
YoY Change 42.75% 37.35% 76.1%
% of Gross Profit 2125.0%
Depreciation & Amortization $140.0K $120.0K $100.0K
YoY Change 40.0% 20.0% 25.0%
% of Gross Profit 83.33%
Operating Expenses $8.240M $3.878M $6.800M
YoY Change 21.18% -18.15% 60.38%
Operating Profit -$6.961M -$6.680M
YoY Change 50.48% 65.96%
Interest Expense $180.0K -$30.00K $13.00K
YoY Change 1284.62% -94.83% -80.0%
% of Operating Profit
Other Income/Expense, Net -$32.00K $0.00
YoY Change -94.5% -100.0%
Pretax Income -$7.800M -$6.990M -$6.480M
YoY Change 20.37% 34.17% -59.8%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.798M -$6.993M -$6.480M
YoY Change 20.34% 34.27% -59.8%
Net Earnings / Revenue -2920.6% -4511.61% -5400.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.926M -$1.739M -$1.666M
COMMON SHARES
Basic Shares Outstanding 80.46M 80.50M shares 77.82M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 Q4 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.14M $50.03M $48.17M
YoY Change 4.09% 0.42% 208.19%
Cash & Equivalents $50.14M $50.03M $48.17M
Short-Term Investments
Other Short-Term Assets $1.050M $370.0K $930.0K
YoY Change 12.9% -40.32% 181.82%
Inventory $66.00K $69.00K $63.00K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $51.26M $50.47M $49.16M
YoY Change 4.27% -0.12% 204.52%
LONG-TERM ASSETS
Property, Plant & Equipment $2.042M $1.440M $857.0K
YoY Change 138.27% 57.38% -17.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $106.0K $83.00K $89.00K
YoY Change 19.1% -9.78% -9.18%
Total Long-Term Assets $2.227M $1.602M $1.025M
YoY Change 117.27% 47.51% -16.73%
TOTAL ASSETS
Total Short-Term Assets $51.26M $50.47M $49.16M
Total Long-Term Assets $2.227M $1.602M $1.025M
Total Assets $53.49M $52.07M $50.19M
YoY Change 6.58% 0.88% 188.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.387M $495.0K $326.0K
YoY Change 325.46% 59.16% -49.14%
Accrued Expenses $2.257M $2.028M $822.0K
YoY Change 174.57% 30.08% 5.38%
Deferred Revenue
YoY Change
Short-Term Debt $130.0K $300.0K $380.0K
YoY Change -65.79%
Long-Term Debt Due $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% 0.0%
Total Short-Term Liabilities $4.761M $3.716M $1.893M
YoY Change 151.51% 28.09% -77.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0% -50.0%
Other Long-Term Liabilities $30.00K $40.00K $0.00
YoY Change 300.0% -100.0%
Total Long-Term Liabilities $30.00K $40.00K $10.00K
YoY Change 200.0% 100.0% -66.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.761M $3.716M $1.893M
Total Long-Term Liabilities $30.00K $40.00K $10.00K
Total Liabilities $4.793M $3.760M $1.902M
YoY Change 152.0% 29.03% -77.37%
SHAREHOLDERS EQUITY
Retained Earnings -$122.3M
YoY Change
Common Stock $171.0M $162.8M $140.5M
YoY Change 21.7% 211337.66% 216049.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $48.70M $48.31M $48.28M
YoY Change
Total Liabilities & Shareholders Equity $53.49M $52.07M $50.19M
YoY Change 6.58% 0.88% 188.84%

Cashflow Statement

Concept 2015 Q1 2014 Q4 2014 Q1
OPERATING ACTIVITIES
Net Income -$7.798M -$6.993M -$6.480M
YoY Change 20.34% 34.27% -59.8%
Depreciation, Depletion And Amortization $140.0K $120.0K $100.0K
YoY Change 40.0% 20.0% 25.0%
Cash From Operating Activities -$5.610M -$4.310M -$5.400M
YoY Change 3.89% 10.51% 95.65%
INVESTING ACTIVITIES
Capital Expenditures -$650.0K -$290.0K -$120.0K
YoY Change 441.67% -1550.0% -187.59%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$650.0K -$290.0K -$120.0K
YoY Change 441.67% 1350.0% -25.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.370M 240.0K 3.870M
YoY Change 64.6% -38.46% 4.03%
NET CHANGE
Cash From Operating Activities -5.610M -4.310M -5.400M
Cash From Investing Activities -650.0K -290.0K -120.0K
Cash From Financing Activities 6.370M 240.0K 3.870M
Net Change In Cash 110.0K -4.360M -1.650M
YoY Change -106.67% 23.51% -306.25%
FREE CASH FLOW
Cash From Operating Activities -$5.610M -$4.310M -$5.400M
Capital Expenditures -$650.0K -$290.0K -$120.0K
Free Cash Flow -$4.960M -$4.020M -$5.280M
YoY Change -6.06% 2.55% 82.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
78000
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
140419000
CY2014Q4 us-gaap Inventory Net
InventoryNet
69000
CY2014Q1 us-gaap Inventory Net
InventoryNet
63000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
372000
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
931000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
50468000
CY2014Q1 us-gaap Assets Current
AssetsCurrent
49161000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1440000
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
857000
CY2014Q4 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
79000
CY2014Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
79000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
83000
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
89000
CY2014Q4 us-gaap Assets
Assets
52070000
CY2014Q1 us-gaap Assets
Assets
50186000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
495000
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
326000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2028000
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
822000
CY2014Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
646000
CY2014Q1 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
345000
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
241000
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
13000
CY2014Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
8000
CY2014Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
10000
CY2014Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
5000
CY2014Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
114497000
CY2014Q1 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
92213000
CY2013Q4 us-gaap Revenue From Grants
RevenueFromGrants
38000
us-gaap Revenue From Grants
RevenueFromGrants
44000
CY2014Q4 us-gaap Revenues
Revenues
155000
CY2013Q4 us-gaap Revenues
Revenues
135000
us-gaap Revenues
Revenues
304000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13350000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9281000
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-6961000
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4626000
CY2014Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
40000
CY2013Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
586000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-24000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5397000
us-gaap Interest Expense
InterestExpense
13000
CY2014Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
8000
CY2013Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
4000
us-gaap Investment Income Interest
InvestmentIncomeInterest
22000
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78113639
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78113639
us-gaap Sales Revenue Net
SalesRevenueNet
139000
onvo Revenue From Research Collaborations
RevenueFromResearchCollaborations
214000
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50186000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
48284000
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Revenue From Grants
RevenueFromGrants
50000
us-gaap Revenues
Revenues
264000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8740000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5487000
CY2014Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3878000
CY2013Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2379000
CY2013Q4 onvo Revenue From Research Collaborations
RevenueFromResearchCollaborations
97000
onvo Revenue From Research Collaborations
RevenueFromResearchCollaborations
121000
CY2014Q4 us-gaap Revenue From Grants
RevenueFromGrants
9000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79225692
CY2013Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
77235976
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
44000
CY2014Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-3000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2014Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-32000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3716000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
48310000
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
80458648
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50027000
CY2014Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
298000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52070000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
80458406
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80458406
CY2014Q4 us-gaap Sales Revenue Net
SalesRevenueNet
139000
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
43000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.770
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.49
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.54
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9690
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48167000
CY2014Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
377000
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1893000
CY2014Q4 us-gaap Liabilities
Liabilities
3760000
CY2014Q1 us-gaap Liabilities
Liabilities
1902000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
80000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
162727000
CY2014Q4 onvo Revenue From Research Collaborations
RevenueFromResearchCollaborations
7000
us-gaap Dilutive Securities
DilutiveSecurities
0
us-gaap Dilutive Securities
DilutiveSecurities
0
CY2013Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6400000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.00
CY2013Q4 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2014Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8200000
CY2011 onvo Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
P5Y
CY2013Q4 onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
60176
onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
8647
onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
1878104
CY2013Q4 onvo Increased Office Space Headquarters
IncreasedOfficeSpaceHeadquarters
15268
us-gaap Investment Income Interest
InvestmentIncomeInterest
11000
CY2013Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-582000
CY2014Q4 us-gaap Profit Loss
ProfitLoss
-6993000
CY2013Q4 us-gaap Profit Loss
ProfitLoss
-5208000
us-gaap Profit Loss
ProfitLoss
-22284000
us-gaap Profit Loss
ProfitLoss
-19366000
CY2014Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
80491120
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
334000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
288000
onvo Payment For Expense On Warrant Modification
PaymentForExpenseOnWarrantModification
12000
us-gaap Share Based Compensation
ShareBasedCompensation
5215000
us-gaap Share Based Compensation
ShareBasedCompensation
2840000
us-gaap Cost Of Services Amortization
CostOfServicesAmortization
556000
us-gaap Cost Of Services Amortization
CostOfServicesAmortization
182000
onvo Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
-94000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-318000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
25000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
169000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-330000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1206000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
779000
onvo Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
254000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
268000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-42000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-13991000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-10161000
onvo Increase Decrease In Cash Deposits Released From Restriction
IncreaseDecreaseInCashDepositsReleasedFromRestriction
9000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
867000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
156000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-867000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-147000
onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
16512000
onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
44310000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
213000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
195000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
7000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
7000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
16718000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
44498000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1860000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
34190000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15628000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49818000
onvo Deduction In Warrant Liability
DeductionInWarrantLiability
55000
onvo Deduction In Warrant Liability
DeductionInWarrantLiability
10522000
onvo Warrant Reclassified Equity Instruments
WarrantReclassifiedEquityInstruments
0
onvo Warrant Reclassified Equity Instruments
WarrantReclassifiedEquityInstruments
767000
onvo Issued Warrants To Purchase Share Of Common Stock For Consulting Services Shares
IssuedWarrantsToPurchaseShareOfCommonStockForConsultingServicesShares
75000
onvo Issued Warrants To Purchase Shares Of Common Stock Or Consulting Services
IssuedWarrantsToPurchaseSharesOfCommonStockOrConsultingServices
404000
onvo Leasehold Improvements Funded By Lease Incentive
LeaseholdImprovementsFundedByLeaseIncentive
47000
onvo Operating Leases Monthly Base Rent Expense
OperatingLeasesMonthlyBaseRentExpense
38800
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Significant estimates used in preparing the condensed consolidated financial statements include those assumed in computing the valuation of warrants, revenue recognized under the proportional performance model, the valuation of stock-based compensation expense, and the valuation allowance on deferred tax assets. </p></div>
us-gaap Revenue Recognition Multiple Element Arrangements
RevenueRecognitionMultipleElementArrangements
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Revenue Arrangements with Multiple Deliverables </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company periodically enters into revenue arrangements that contain multiple deliverables. Judgment is required to properly identify the accounting units of the multiple deliverable transactions and to determine the manner in which revenue should be allocated among the accounting units. Moreover, judgment is used in interpreting the commercial terms and determining when all criteria of revenue recognition have been met for each deliverable in order for revenue recognition to occur in the appropriate accounting period. For multiple deliverable agreements, consideration is allocated at the inception of the agreement to all deliverables based on their relative selling price. The relative selling price for each deliverable is determined using vendor-specific objective evidence (&#8220;VSOE&#8221;) of selling price or third-party evidence of selling price if VSOE does not exist. If neither VSOE nor third-party evidence of selling price exists, the Company uses its best estimate of the selling price for the deliverable. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While changes in the allocation of the arrangement consideration between the units of accounting will not affect the amount of total revenue recognized for a particular sales arrangement, any material changes in these allocations could impact the timing of revenue recognition, which could affect the Company&#8217;s results of operations. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company expects to periodically receive license fees for non-exclusive research licensing associated with funded research projects. License fees under these arrangements are recognized over the term of the contract or development period as it has been determined that such licenses do not have stand-alone value. </p></div>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
35443
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6668145
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Reclassifications </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain reclassifications were made to the Condensed Consolidated Balance Sheet as of March&#160;31, 2014 and the Unaudited Condensed Consolidated Statement of Operations for the three and nine months ended December&#160;31, 2013 in order to conform to the presentation of the Condensed Consolidated Balance Sheet as of December&#160;31, 2014 and the Condensed Consolidated Statement of Operations for the three and nine months ended December&#160;31, 2014. The reclassifications did not have any effect on previously reported net loss or financial position. </p></div>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
205000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
52500
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
315995
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5935888
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
867058
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
31000
CY2014Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
31000
us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
The estimated useful lives of the fixed assets range between two and seven years.
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2014Q4 us-gaap Dilutive Securities
DilutiveSecurities
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8200000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6400000
CY2012 onvo Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
P5Y
CY2014Q4 onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
0
CY2013Q4 onvo Class Of Warrant Or Right Reclassification From Liability Instruments To Equity Instruments
ClassOfWarrantOrRightReclassificationFromLiabilityInstrumentsToEquityInstruments
269657
CY2013Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
4.50
CY2013Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
43400000
CY2013Q3 us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
3200000
CY2014Q4 onvo Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
100000
CY2013Q4 onvo Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
533533
onvo Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
210600
onvo Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
2404519
CY2014Q4 onvo Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
100000
CY2013Q4 onvo Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
600306
onvo Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
211647
onvo Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
2878863
CY2014Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
9961
CY2013Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
76501
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
98707
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
83801
CY2014Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10612
CY2013Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
76501
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
99358
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
83801
CY2014Q4 onvo Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Upon Return Of Common Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUponReturnOfCommonShares
3703
CY2013Q4 onvo Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Upon Return Of Common Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUponReturnOfCommonShares
3703
onvo Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Upon Return Of Common Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUponReturnOfCommonShares
109808
onvo Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Upon Return Of Common Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUponReturnOfCommonShares
164243
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
200000
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
573495
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2559635
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.87
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.23
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
7.25
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.18
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.21
CY2014Q4 onvo Warrant Earning Period Through Issuance Of Common Stock
WarrantEarningPeriodThroughIssuanceOfCommonStock
P17M
CY2013Q4 us-gaap Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate
0.03
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.01
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
20482823
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
462948
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
18539044
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
11124896
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y9M26D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M10D
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.823
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.771
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.839
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0167
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0078
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0164
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0082
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.86
CY2014Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
15100000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
450176
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
8647
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
2485233
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
650000
CY2012 onvo Number Of Agreement With Consultants For Services
NumberOfAgreementWithConsultantsForServices
4
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
75000
CY2013Q4 onvo Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
P5Y
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0060
CY2014Q4 onvo Warrant Or Right Expense Or Revenue Recognized
WarrantOrRightExpenseOrRevenueRecognized
39000
onvo Warrant Or Right Expense Or Revenue Recognized
WarrantOrRightExpenseOrRevenueRecognized
241000
CY2013Q4 onvo Warrant Earning Period Through Issuance Of Common Stock
WarrantEarningPeriodThroughIssuanceOfCommonStock
P12M
onvo Common Stock Warrants Issued
CommonStockWarrantsIssued
50000
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
145000
CY2014Q4 onvo Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
P5Y
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7650
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0165
CY2014Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
11253891
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2014Q4 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
235000
CY2013Q4 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
112000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
705000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
322000
CY2014Q4 us-gaap Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate
0.03
onvo Lease Term With Option To Extend
LeaseTermWithOptionToExtend
P48M
CY2013Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2016-08-01
CY2013Q4 onvo Operating Leases Monthly Rent Expense
OperatingLeasesMonthlyRentExpense
38934
CY2013Q4 onvo Additional Leased Office Space
AdditionalLeasedOfficeSpace
15539
CY2013Q4 onvo Additional Office Space
AdditionalOfficeSpace
14500
CY2013Q4 onvo Office Space Area Under Lease Agreement
OfficeSpaceAreaUnderLeaseAgreement
30807
onvo Lease Amendment Effective Date
LeaseAmendmentEffectiveDate
2014-09-01
CY2013Q4 onvo Operating Leases Monthly Base Rent Expense
OperatingLeasesMonthlyBaseRentExpense
38800
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Next Rolling Twelve Months
OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths
242000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Two
OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo
979000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Three
OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree
984000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Four
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour
1001000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
6764000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Five
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFive
1031000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
2527000

Files In Submission

Name View Source Status
0001564590-15-000541-index-headers.html Edgar Link pending
0001564590-15-000541-index.html Edgar Link pending
0001564590-15-000541.txt Edgar Link pending
0001564590-15-000541-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
onvo-10q_20141231.htm Edgar Link pending
onvo-20141231.xml Edgar Link completed
onvo-20141231.xsd Edgar Link pending
onvo-20141231_cal.xml Edgar Link unprocessable
onvo-20141231_def.xml Edgar Link unprocessable
onvo-20141231_lab.xml Edgar Link unprocessable
onvo-20141231_pre.xml Edgar Link unprocessable
onvo-ex31_201412316.htm Edgar Link pending
onvo-ex31_201412318.htm Edgar Link pending
onvo-ex32_201412317.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending